- ByInvesting.com-
Investing.com -- Novo Nordisk A/S has canceled contracts for new recruits just days or weeks before their start dates as part of...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
262.3 | 263.0 | 259.7 | -1.2 | -0.46% | 964.47K | ||
780.4 | 784.2 | 775.2 | -3.2 | -0.41% | 204.6K | ||
1,413.0 | 1,434.0 | 1,406.5 | -27.0 | -1.88% | 297.72K | ||
358.8 | 360.1 | 353.7 | 0.0 | 0.00% | 5.22M | ||
13,135 | 13,440 | 13,135 | -205 | -1.54% | 31.34K | ||
405.6 | 412.3 | 405.6 | -6.1 | -1.48% | 929.55K | ||
13,100 | 13,360 | 13,040 | -170 | -1.28% | 7.55K | ||
607.5 | 625.5 | 607.5 | -19.0 | -3.03% | 86.88K | ||
1,588.0 | 1,606.5 | 1,588.0 | -24.5 | -1.52% | 90.7K | ||
127.0 | 131.4 | 127.0 | -4.0 | -3.05% | 2.12M | ||
244.0 | 246.8 | 242.2 | +1.0 | +0.41% | 232.72K | ||
167.8 | 168.0 | 167.0 | 0.0 | 0.00% | 506.54K | ||
612.8 | 620.6 | 608.2 | +4.2 | +0.69% | 245.61K | ||
96.3 | 97.6 | 95.5 | -1.2 | -1.23% | 477.06K | ||
685.0 | 690.0 | 681.0 | -5.5 | -0.80% | 91.75K | ||
881.0 | 901.4 | 881.0 | -18.4 | -2.05% | 208.95K | ||
241 | 247 | 241 | -6 | -2.43% | 392.79K | ||
437.40 | 444.40 | 432.60 | -4.00 | -0.91% | 271.54K | ||
186.60 | 187.20 | 185.50 | +0.80 | +0.43% | 328.78K | ||
193.15 | 202.90 | 193.15 | -6.55 | -3.28% | 1.12M |
Investing.com -- Novo Nordisk A/S has canceled contracts for new recruits just days or weeks before their start dates as part of...
Investing.com -- European consumer ingredients stocks have experienced a difficult second quarter, with more top-line misses than...
Investing.com -- European life sciences stocks have faced challenges in 2025, with Q2 top-line disappointments raising concerns...
Novo Nordisk A/S (NYSE:NVO) announced that CEO Lars Fruergaard Jørgensen is stepping down amid mounting challenges, with...
Rate cuts are on the horizon—discover which sectors are poised to benefit. Defensive stocks could thrive as lower interest rates...
SVB failure could have been avoided if its leaders had paid attention to an internal report As the fallout continues, will Fed and...
No Earning Reports have been scheduled